1.95
전일 마감가:
$1.78
열려 있는:
$1.79
하루 거래량:
1.68M
Relative Volume:
0.58
시가총액:
$128.47M
수익:
-
순이익/손실:
$-86.08M
주가수익비율:
-0.9039
EPS:
-2.1574
순현금흐름:
$-72.06M
1주 성능:
+23.42%
1개월 성능:
-9.30%
6개월 성능:
+116.67%
1년 성능:
+117.85%
Io Biotech Inc Stock (IOBT) Company Profile
명칭
Io Biotech Inc
전화
(457) 070-2980
주소
OLE MAALOES VEH 3, COPENHAGEN
IOBT을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
IOBT
Io Biotech Inc
|
1.95 | 117.27M | 0 | -86.08M | -72.06M | -2.1574 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Io Biotech Inc 주식(IOBT)의 최신 뉴스
News impact scoring models applied to IO Biotech Inc.2025 Risk Factors & Safe Capital Allocation Plans - Newser
Pattern recognition hints at IO Biotech Inc. upsideTrade Analysis Summary & Daily Oversold Stock Bounce Ideas - Newser
Building trade automation scripts for IO Biotech Inc.2025 Market WrapUp & Weekly Chart Analysis and Guides - Newser
Will IO Biotech Inc. stock hit new highs in YEARDividend Hike & AI Powered Market Trend Analysis - خودرو بانک
IO Biotech says cancer vaccine with Merck’s Keytruda outperformed in late-stage study - MSN
IO Biotech’s vaccine misses on mPFS in phase III advanced melanoma trial - The Cancer Letter
What earnings revisions data tells us about IO Biotech Inc.Quarterly Portfolio Report & Long-Term Safe Return Strategies - Newser
Should you hold or exit IO Biotech Inc. nowWeekly Trade Review & Safe Entry Momentum Stock Tips - Newser
Is IO Biotech Inc. forming bullish engulfing patternsTrade Ideas & Reliable Momentum Entry Alerts - خودرو بانک
What data driven models say about IO Biotech Inc.’s futureOptions Play & Advanced Swing Trade Entry Plans - Newser
Is IO Biotech Inc. a top pick in the sectorTrade Entry Summary & Daily Profit Maximizing Trade Tips - خودرو بانک
Applying sector rotation models to IO Biotech Inc.Wall Street Watch & Daily Profit Focused Screening - Newser
Analyst Upgrade: Will IO Biotech Inc. stock hit new highs in YEAR2025 Market Trends & Weekly Chart Analysis and Guides - خودرو بانک
Using Ichimoku Cloud for IO Biotech Inc. technicalsMarket Risk Summary & Capital Efficient Trading Techniques - Newser
IO Biotech’s Strategic Momentum: Evaluating Cylembio’s Pipeline Progress and Investor Engagement as Catalysts for Long-Term Growth - AInvest
IO Biotech Announces Upcoming Investor Conferences and Corporate Update on Cylembio® Development - Quiver Quantitative
IO Biotech to Present at Upcoming Investor Conferences, Highlighting Cylembio Therapeutic Cancer Vaccine Candidate - AInvest
IO Biotech Announces Participation in Upcoming Investor Conferences - The Manila Times
Cancer Vaccine Developer IO Biotech to Present Latest Corporate Updates at Global Healthcare Forums - Stock Titan
Detecting support and resistance levels for IO Biotech Inc.Fed Meeting & Technical Pattern Alert System - Newser
How to track smart money flows in IO Biotech Inc.Trade Risk Summary & Daily Technical Forecast Reports - Newser
What are analysts’ price targets for IO Biotech Inc.July 2025 Update & High Conviction Trade Alerts - خودرو بانک
Price momentum metrics for IO Biotech Inc. explained2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Volatility clustering patterns for IO Biotech Inc.Market Trend Review & Safe Capital Preservation Plans - Newser
Will IO Biotech Inc. benefit from macro trendsIndex Update & Weekly High Return Stock Forecasts - Newser
Can a trend reversal in IO Biotech Inc. lead to recovery2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Analyzing recovery setups for IO Biotech Inc. investorsGDP Growth & Safe Capital Growth Plans - Newser
Is IO Biotech Inc. stock poised for growthRecession Risk & Verified Entry Point Detection - Newser
Using portfolio simulators with IO Biotech Inc. includedNew Guidance & Free Accurate Trade Setup Notifications - Newser
How liquid is IO Biotech Inc. stockJuly 2025 Technicals & Growth Focused Entry Reports - خودرو بانک
What to do if you’re stuck in IO Biotech Inc.Weekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
What to expect from IO Biotech Inc. in the next 30 days2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
How to integrate IO Biotech Inc. into portfolio analysis toolsJuly 2025 Breakouts & Verified High Yield Trade Plans - Newser
Can IO Biotech Inc. navigate macro headwindsJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - خودرو بانک
Does IO Biotech Inc. meet Warren Buffett’s criteria2025 Buyback Activity & Real-Time Volume Surge Alerts - خودرو بانک
Analyzing net buyer seller activity in IO Biotech Inc.July 2025 Market Mood & Verified Technical Trade Signals - Newser
Io Biotech, Inc. shares rise 6.39% intraday due to unspecified reasons. - AInvest
IO Biotech Inc. stock momentum explainedMarket Trend Review & Smart Allocation Stock Reports - Newser
Full technical analysis of IO Biotech Inc. stock2025 Big Picture & Scalable Portfolio Growth Ideas - Newser
Io Biotech Inc (IOBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Io Biotech Inc 주식 (IOBT) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Ahmad Qasim Iftikhar | Chief Medical Officer |
Dec 23 '24 |
Buy |
0.85 |
31,350 |
26,553 |
31,350 |
Zocca Mai-Britt | Chief Executive Officer |
Dec 23 '24 |
Buy |
0.81 |
12,500 |
10,120 |
49,891 |
Sullivan Amy | Chief Financial Officer |
Dec 23 '24 |
Buy |
0.83 |
10,250 |
8,483 |
84,632 |
Smith Devin Whittemore | General Counsel |
Dec 23 '24 |
Buy |
0.81 |
12,000 |
9,720 |
16,938 |
자본화:
|
볼륨(24시간):